|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Current assets: | ||||||||
| Deferred offering costs | ||||||||
| Cash | ||||||||
| Prepaid expenses | ||||||||
| Total current assets | ||||||||
| Long-term prepaid expenses | ||||||||
| Investments held in Trust Account | ||||||||
| Total assets | ||||||||
| Liabilities and Shareholders' Deficit | ||||||||
| Current liabilities: | ||||||||
| Accounts payable and accrued expenses | ||||||||
| Promissory note - related party | ||||||||
| Total current liabilities | ||||||||
| Warrant liabilities | ||||||||
| Forward Purchase Agreement liability | ||||||||
| Deferred underwriters' discount | ||||||||
| Total liabilities | ||||||||
| Class A ordinary shares subject to possible redemption, $0.0001 par value; 22,165,962 shares at redemption value | ||||||||
| Shareholders' Deficit: | ||||||||
| Ordinary shares, value | ||||||||
| Additional paid-in capital | ||||||||
| Accumulated deficit | ||||||||
| Class B Ordinary Shares | ||||||||
| Total shareholders' deficit | ||||||||
| Total Liabilities, Redeemable Ordinary Shares and Shareholders’ Deficit |
Loading...
